ID

12806

Descripción

Administration of GRASPA (Suspension of Erythrocytes Encapsulating L-asparaginase) in Elderly Patients With First Line Acute Lymphoblastic Leukemia; ODM derived from: https://clinicaltrials.gov/show/NCT01523782

Link

https://clinicaltrials.gov/show/NCT01523782

Palabras clave

  1. 21/12/15 21/12/15 -
Subido en

21 de diciembre de 2015

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0

Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Acute Lymphoblastic Leukemia NCT01523782

Eligibility Acute Lymphoblastic Leukemia NCT01523782

Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
aged ≥ 55 years
Descripción

age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
newly diagnosed all without prior treatment
Descripción

all

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0023449
patient capable to receive polychemotherapy (who < 2)
Descripción

polychemotherapy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0013218
with or without meningeal disease
Descripción

meningeal leukemia

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0948840
signed informed consent forms
Descripción

informed consent

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021430
subscribed to social security insurance
Descripción

social security insurance

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0021682
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
all t(9;22) and/or bcr-abl positive
Descripción

all t(9;22) and/or bcr-abl positive

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0279592
UMLS CUI [2]
C2861580
general state incompatible with chemotherapy treatment (who>2)
Descripción

general state incompatible with chemotherapy treatment

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1298650
UMLS CUI [2]
C0392920
presenting with a general or visceral contraindication to intensive treatment
Descripción

contraindication

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1301624
patient with another cancer other than all
Descripción

malignancy

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0006826
severe evolutive infection or hiv seropositive or active hepatitis related to b or c viral infection
Descripción

communicable disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0009450
prior treatment with l-asparaginase (irrespective of the form)
Descripción

l-asparaginase

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0003993
history of grade 3 transfusional incident (life threatening)
Descripción

transfusional incident

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0161840
presenting rare and/or dangerous anti-erythrocyte antibodies thus leading to the unavailable of a phenotype compatible red blood cells
Descripción

anti-erythrocyte antibodies

Tipo de datos

boolean

Alias
UMLS CUI [1]
C1112584
included in another clinical trial during the last 4weeks.
Descripción

study subject participation status

Tipo de datos

boolean

Alias
UMLS CUI [1]
C2348568

Similar models

Eligibility Acute Lymphoblastic Leukemia NCT01523782

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
age
Item
aged ≥ 55 years
boolean
C0001779 (UMLS CUI [1])
all
Item
newly diagnosed all without prior treatment
boolean
C0023449 (UMLS CUI [1])
polychemotherapy
Item
patient capable to receive polychemotherapy (who < 2)
boolean
C0013218 (UMLS CUI [1])
meningeal leukemia
Item
with or without meningeal disease
boolean
C0948840 (UMLS CUI [1])
informed consent
Item
signed informed consent forms
boolean
C0021430 (UMLS CUI [1])
social security insurance
Item
subscribed to social security insurance
boolean
C0021682 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
all t(9;22) and/or bcr-abl positive
Item
all t(9;22) and/or bcr-abl positive
boolean
C0279592 (UMLS CUI [1])
C2861580 (UMLS CUI [2])
general state incompatible with chemotherapy treatment
Item
general state incompatible with chemotherapy treatment (who>2)
boolean
C1298650 (UMLS CUI [1])
C0392920 (UMLS CUI [2])
contraindication
Item
presenting with a general or visceral contraindication to intensive treatment
boolean
C1301624 (UMLS CUI [1])
malignancy
Item
patient with another cancer other than all
boolean
C0006826 (UMLS CUI [1])
communicable disease
Item
severe evolutive infection or hiv seropositive or active hepatitis related to b or c viral infection
boolean
C0009450 (UMLS CUI [1])
l-asparaginase
Item
prior treatment with l-asparaginase (irrespective of the form)
boolean
C0003993 (UMLS CUI [1])
transfusional incident
Item
history of grade 3 transfusional incident (life threatening)
boolean
C0161840 (UMLS CUI [1])
anti-erythrocyte antibodies
Item
presenting rare and/or dangerous anti-erythrocyte antibodies thus leading to the unavailable of a phenotype compatible red blood cells
boolean
C1112584 (UMLS CUI [1])
study subject participation status
Item
included in another clinical trial during the last 4weeks.
boolean
C2348568 (UMLS CUI [1])

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial